NEW YORK (Reuters Health) – A novel, non-culture-based assay called the ribosomal RNA synthesis (RS) ratio provides a molecular metric to assess the effects of candidate tuberculosis (TB)
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok